nodepositbonuscasino2021| Yuandong Biotech: Berprost Sodium Tablets Obtained Drug Registration Certificate

News summary

[Yuandong Biological: Berprost Sodium Tablets Obtained Drug Registration Certificate] Securities Times e Company Newsnodepositbonuscasino2021Yuandong Biotech (688513) announced on the evening of May 21 that it recently received the "Drug Registration Certificate" for berprost sodium tablets approved and issued by the State Food and Drug Administration. The indication for berprost sodium tablets is to improve chronic diseases.nodepositbonuscasino2021...

Newsletter text

[Yuandong Biotech: Berprost Sodium Tablets Obtained Drug Registration Certificate] Securities Times e Company News, Yuandong Biotech (688513) announced on the evening of May 21 that it recently received the approval and issuance of Berprost Sodium Tablets by the State Food and Drug Administration."Drug Registration Certificate", Berprost Sodium Tablets are indicated for improving symptoms such as ulcers, intermittent claudication, pain and cold sensation caused by chronic arterial occlusive disease.

(: Congratulations